Noriaki Kato

Summary

Affiliation: Sanwa Kagaku Kenkyusho Co
Country: Japan

Publications

  1. doi request reprint Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: potential roles of vascular endothelial growth factor and nitric oxide
    Noriaki Kato
    Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho Co, Ltd, Mie, Japan
    Eur J Pharmacol 606:187-90. 2009
  2. ncbi request reprint Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway
    Takeshi Suzuki
    Drug Development Research Laboratories, Sanwa Kagaku Kenkyusho Co, Ltd, Mie, Japan
    J Neurochem 91:1430-8. 2004
  3. ncbi request reprint Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats
    Noriaki Kato
    Central Research Laboratory, Sanwa Kagaku Kenkyusho Co, Ltd, 363 Shiosaki, Hokusei, Mie 511 0406, Inabe, Japan
    J Diabetes Complications 17:374-9. 2003
  4. ncbi request reprint Change in blood kinin and plasma porcine pancreatic kallikrein concentrations after oral administration of kallikrein formulation in dog
    Yoshika Yasuda
    Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho Co, Ltd, Japan
    Biol Pharm Bull 34:1518-21. 2011

Detail Information

Publications4

  1. doi request reprint Kallidinogenase normalizes retinal vasopermeability in streptozotocin-induced diabetic rats: potential roles of vascular endothelial growth factor and nitric oxide
    Noriaki Kato
    Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho Co, Ltd, Mie, Japan
    Eur J Pharmacol 606:187-90. 2009
    ..The current study showed beneficial effects of kallidinogenase on increased retinal vascular permeability and VEGF in diabetic rats, suggesting that kallidinogenase may be effective for simple retinopathy in patients with diabetes...
  2. ncbi request reprint Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway
    Takeshi Suzuki
    Drug Development Research Laboratories, Sanwa Kagaku Kenkyusho Co, Ltd, Mie, Japan
    J Neurochem 91:1430-8. 2004
    ..Together, the enhanced polyol pathway activity under high-glucose conditions seems to elicit reduced NT-3-induced NGF production in Schwann cells. Enhanced oxidative stress linked to the polyol pathway activity may mediate this process...
  3. ncbi request reprint Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats
    Noriaki Kato
    Central Research Laboratory, Sanwa Kagaku Kenkyusho Co, Ltd, 363 Shiosaki, Hokusei, Mie 511 0406, Inabe, Japan
    J Diabetes Complications 17:374-9. 2003
    ..These results suggest that fidarestat, by virtue of its long-term correction of the accelerated polyol pathway, has a potential role in preventing the progression of diabetic retinopathy...
  4. ncbi request reprint Change in blood kinin and plasma porcine pancreatic kallikrein concentrations after oral administration of kallikrein formulation in dog
    Yoshika Yasuda
    Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho Co, Ltd, Japan
    Biol Pharm Bull 34:1518-21. 2011
    ..6 ng/ml vs. 49.6 ± 1.4 ng/ml; mean ± S.E.M, n = 4, p < 0.05). In conclusion, PPK was considered to be absorbed after oral administration and to exert its pharmacological action via kinins produced by kininogen degradation in dogs...